Invasive Group A Streptococcal Infection

Last updated: February 7, 2024
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pressure Ulcers

Treatment

N/A

Clinical Study ID

NCT05788861
ISAI
  • Ages 1-17
  • All Genders

Study Summary

This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age<18 years
  • Documented invasive Group A Streptococcus infection (identification of GAS in anormally sterile site or from another site in case of toxin shock or necrotizingdermo-hypodermatitis)

Exclusion

Exclusion Criteria:

  • Opposition of the patient or his/her legal representative

Study Design

Total Participants: 100
Study Start date:
September 01, 2022
Estimated Completion Date:
September 01, 2026

Study Description

The main of this study is to identify and record cases of invasive and severe infections due to Streptococcus pyogenes. In order to evaluate the incidence of severe forms of disease and the possible contributing factors, and to optimize their management.

Admitted patients to intensive care or critical care units in reported via Santé Publique France may also be included in this study.

Secondly, epidemiological, clinical, bacteriological data of all severe or not cases, of group A Streptococcal infections will be compiled to describe their characteristics, and try to explain this recrudescence as well as possible.

Connect with a study center

  • ACTIV

    Créteil, 94000
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.